Potential Tool To Capture Circulating Cancer Cells

A modified opsonin bound to antibody (FcMBL) could become a broad-spectrum potent tool in the treatment of several cancer types by binding to carbohydrate ligands on the surface of cancer cells, according to a recent study conducted at the Wyss Institute at Harvard University.
Email bookmark
Font : A-A+

Related Links